基本信息
浏览量:1
职业迁徙
个人简介
Research summary
The complexity of genetic eye diseases is unprecedented. The research focus of our lab is inherited eye disease, from gene discovery to defining cellular function through to development of potential therapies. Our molecular genetic, functional and phenotypic studies have continually resulted in new discoveries that influence patient care. We have defined genetic mechanisms of disease and function of disease proteins in the retina, lens, cornea and developing eye, and have harnessed technological advances in next generation sequencing and stem cell biology to address our research questions.
One of our specialties is X-linked forms of retinal degeneration. Some notable examples include identification of the cause of RP23 as a deep intronic mutation resulting in introduction of cryptic exon in a ciliopathy gene. We also described progressive cone dystrophy associated with a novel cone opsin misfolding mutation, and subsequently identified SNP haplotypes that result in splicing defects, leading to molecular understanding of cone opsin array mutational mechanisms and clinical outcome.
In collaboration with Prof Mike Cheetham, we have defined the function of the X-linked retinitis pigmentosa protein RP2. Following on from our important functional studies, we have reprogrammed patient derived iPSCs into RPE cells, in collaboration with Prof Pete Coffey, and successfully shown that readthrough drugs can restore protein function and hence may be a viable treatment for patients with nonsense mutations.
Applying a similar research pathway from genetic mechanism to cellular function, our studies have shown that X-linked cataract is allelic with Nance-Horan Syndrome (NHS), and we defined the function of NHS as a regulator of actin cytoskeletal dynamics and cell size.
We were the first to describe identification of the X-linked megalocornea gene, with consequent effects on brain morphology, influencing our understanding of eye development.
I have developed a successful research program on corneal dystrophies in collaboration with Mr Stephen Tuft, including complex and monogenic diseases, from gene discovery through to developing therapies. This includes a planned GWAS, RNA-seq and whole genome sequencing approach to study keratoconus, and to translate any significant associations into meaningful biological and pathological context.
The complexity of genetic eye diseases is unprecedented. The research focus of our lab is inherited eye disease, from gene discovery to defining cellular function through to development of potential therapies. Our molecular genetic, functional and phenotypic studies have continually resulted in new discoveries that influence patient care. We have defined genetic mechanisms of disease and function of disease proteins in the retina, lens, cornea and developing eye, and have harnessed technological advances in next generation sequencing and stem cell biology to address our research questions.
One of our specialties is X-linked forms of retinal degeneration. Some notable examples include identification of the cause of RP23 as a deep intronic mutation resulting in introduction of cryptic exon in a ciliopathy gene. We also described progressive cone dystrophy associated with a novel cone opsin misfolding mutation, and subsequently identified SNP haplotypes that result in splicing defects, leading to molecular understanding of cone opsin array mutational mechanisms and clinical outcome.
In collaboration with Prof Mike Cheetham, we have defined the function of the X-linked retinitis pigmentosa protein RP2. Following on from our important functional studies, we have reprogrammed patient derived iPSCs into RPE cells, in collaboration with Prof Pete Coffey, and successfully shown that readthrough drugs can restore protein function and hence may be a viable treatment for patients with nonsense mutations.
Applying a similar research pathway from genetic mechanism to cellular function, our studies have shown that X-linked cataract is allelic with Nance-Horan Syndrome (NHS), and we defined the function of NHS as a regulator of actin cytoskeletal dynamics and cell size.
We were the first to describe identification of the X-linked megalocornea gene, with consequent effects on brain morphology, influencing our understanding of eye development.
I have developed a successful research program on corneal dystrophies in collaboration with Mr Stephen Tuft, including complex and monogenic diseases, from gene discovery through to developing therapies. This includes a planned GWAS, RNA-seq and whole genome sequencing approach to study keratoconus, and to translate any significant associations into meaningful biological and pathological context.
研究兴趣
论文共 240 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Nikolas Pontikos, William Woof,Miriam Bauwens,Saoud Al-Khuzaei,Behnam Javanmardi,Michalis Georgiou,Malena Daich Varela, Thales Antonio Cabral De Guimaraes, Muhammad Moghul, Alice Davidson, Panos Sergouniotis,Jamie Ellingford,
EUROPEAN JOURNAL OF HUMAN GENETICS (2024): 5-6
引用0浏览0引用
0
0
Christina Zarouchlioti,Stephanie Efthymiou, Stefano Fracchini,Natalia Dominik,Nihar Bhattacharyya,Siyin Liu, Marcos Abreu Costa,Anita Szabo,Amanda N Sadan, Albert Jun,Enrico Bugiardini,Henry Houlden,
biorxiv(2024)
bioRxiv (Cold Spring Harbor Laboratory) (2024)
JAMA Ophthalmologyno. 10 (2023): 956-956
引用2浏览0引用
2
0
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCEno. 8 (2023)
引用0浏览0引用
0
0
Freddie Braddock,Anita Szabo,Nikolas Pontikos,Pirro Hysi,Stephen Tuft,Alice Davidson,Alison Hardcastle
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCEno. 8 (2023)
引用0浏览0引用
0
0
American journal of ophthalmology (2023): 112-120
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn